VCU Massey Cancer Center: Advancements in Pancreatic Cancer Treatment Show Promise

Written By Gaurav Bilolikar

On November 10, 2023, the VCU Massey Cancer Center released an article detailing new preclinical research that offers hope for pancreatic cancer patients. This study, involving polyinosine-polycytidylic acid (pIC) delivered directly into tumor cells, has shown potential in suppressing tumor growth and increasing survival rates in animal models. This innovative approach is an important step forward in treating one of the most challenging forms of cancer.

Read the full article on the VCU Massey Cancer Center website for more information.

Gaurav Bilolikar
Previous

Medical Xpress: Innovative Pancreatic Cancer Treatment Expands Survival Prospects
Next

IMPRS: Biomarker for Early Prediction of COVID-19 Severity Identified